Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Plug Power private exchange offer
A total of $138.8 million aggregate principal amount of existing convertible senior notes were exchanged
Haitong Unitrust MTN program update and CNY1 billion drawdown
The investment-grade notes are due 2027
Beazer Homes USA $250 million notes offering
The high-yield notes are due 2031
Exchange transaction for Sabre exchangeable notes
We advised Sabre on its exchange of exchangeable senior notes
REV Group $127.5 million secondary offering
We advised REV Group on its SEC-registered secondary stock offering
Westrock Coffee at-the-market program
The shares are listed on Nasdaq
Tellurian $366.1 million at-the-market offering
The shares are listed on the NYSE
MicroStrategy $603.75 million convertible notes offering
The convertible notes are due 2031
Trial Holdings ¥44.6 billion IPO
The shares are listed on the Tokyo Stock Exchange
LKQ €750 million notes offering
The 4.125% notes are due 2031